Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
LTH
|
Partners Group Private Equity (Master Fund), LLC |
SELL
Open market or private sale
|
Indirect | 1,061,014 Reduced 0.0% |
$31,968,351
$30.13 p/Share
|
Mar 03
2025 |
LTH
|
Green Ltf Holdings Ii LP |
SELL
Open market or private sale
|
Direct | 9,871,687 Reduced 93.48% |
$297,433,929
$30.13 p/Share
|
Mar 03
2025 |
HRMY
|
Jeffrey Dierks
CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 4,869 Reduced 100.0% |
$160,287
$32.92 p/Share
|
Mar 03
2025 |
ALEC
|
Marc Grasso
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 18,091 Reduced 5.47% |
$26,593
$1.47 p/Share
|
Mar 03
2025 |
LTH
|
John G Danhakl |
SELL
Open market or private sale
|
Indirect | 9,871,687 Reduced 0.0% |
$297,433,929
$30.13 p/Share
|
Mar 03
2025 |
ALEC
|
Arnon Rosenthal
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 40,330 Reduced 1.61% |
$59,285
$1.47 p/Share
|
Mar 03
2025 |
DASH
|
Stanley Tang |
SELL
Open market or private sale
|
Direct | 48,423 Reduced 72.59% |
$9,730,117
$200.94 p/Share
|
Mar 03
2025 |
DASH
|
Stanley Tang |
SELL
Open market or private sale
|
Indirect | 215,067 Reduced 0.0% |
$43,206,960
$200.9 p/Share
|
Mar 03
2025 |
BLUE
|
Andrew Obenshain
President and CEO |
SELL
Open market or private sale
|
Direct | 921 Reduced 4.78% |
$3,610
$3.92 p/Share
|
Mar 03
2025 |
ALEC
|
Sara Kenkare Mitra
President and Head of R&D |
SELL
Open market or private sale
|
Direct | 29,073 Reduced 5.14% |
$42,737
$1.47 p/Share
|
Mar 03
2025 |
LTH
|
John Kristofer Galashan |
SELL
Open market or private sale
|
Indirect | 9,871,687 Reduced 0.0% |
$297,433,929
$30.13 p/Share
|
Mar 03
2025 |
VCEL
|
Jonathan Mark Hopper
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 13.14% |
$495,300
$49.53 p/Share
|
Mar 03
2025 |
DOCS
|
Kira Scherer Wampler
Director |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 10.74% |
$141,780
$70.89 p/Share
|
Mar 03
2025 |
VCEL
|
Joseph Anthony Mara Jr
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 39.19% |
$445,770
$49.53 p/Share
|
Mar 03
2025 |
VCEL
|
Heidi Hagen |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 23.9% |
$445,770
$49.53 p/Share
|
Mar 03
2025 |
BLUE
|
Thomas J Klima |
SELL
Open market or private sale
|
Direct | 500 Reduced 5.97% |
$1,960
$3.92 p/Share
|
Mar 03
2025 |
VCEL
|
Michael Halpin
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 39.16% |
$495,200
$49.52 p/Share
|
Mar 03
2025 |
BLUE
|
Richard A Colvin
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 584 Reduced 7.13% |
$2,289
$3.92 p/Share
|
Mar 03
2025 |
INTA
|
Scott Fitzgerald
Chief Marketing Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 6.31% |
$192,150
$64.05 p/Share
|
Mar 03
2025 |
EMN
|
Michelle H Caveness
SVP & Chf. Mfg. Ofc. |
SELL
Open market or private sale
|
Direct | 1,147 Reduced 49.57% |
$112,990
$98.51 p/Share
|
Mar 03
2025 |
UPST
|
Kerry Whorton Cooper
Director |
SELL
Open market or private sale
|
Indirect | 500 Reduced 0.0% |
$34,045
$68.09 p/Share
|
Mar 03
2025 |
DPZ
|
Andrew Balson |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 45.71% |
$2,951,460
$491.91 p/Share
|
Mar 03
2025 |
UIHC
|
Christopher Griffith
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 40,305 Reduced 23.04% |
$481,241
$11.94 p/Share
|
Mar 03
2025 |
INTA
|
John T Hall
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 0.15% |
$515,840
$64.48 p/Share
|
Mar 03
2025 |
VRTX
|
David Altshuler
EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 3,231 Reduced 9.8% |
$1,583,190
$490.0 p/Share
|
Mar 03
2025 |
TEVA
|
Eric A Hughes |
SELL
Open market or private sale
|
Direct | 19,726 Reduced 79.22% |
$319,363
$16.19 p/Share
|
Mar 03
2025 |
CTSH
|
John Sunshin Kim
CLO, CAO & Corporate Secretary |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 12.44% |
$418,000
$83.6 p/Share
|
Mar 03
2025 |
PBH
|
Mary Beth Fritz
SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct | 6,297 Reduced 25.06% |
$537,700
$85.39 p/Share
|
Mar 03
2025 |
BATRK
|
Gregory John Heller
EVP, CLO & Secretary |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 62.69% |
$1,025,000
$41.0 p/Share
|
Mar 03
2025 |
CBIO
|
Songjiang Ma
President |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$22,460
$11.23 p/Share
|
Mar 03
2025 |
CVLT
|
Allison Pickens
Director |
SELL
Open market or private sale
|
Direct | 1,232 Reduced 20.88% |
$211,879
$171.98 p/Share
|
Mar 03
2025 |
PAYS
|
Jeffery Bradford Baker
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 28,396 Reduced 11.49% |
$69,286
$2.44 p/Share
|
Mar 03
2025 |
CHWY
|
Sumit Singh
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 201 Reduced 0.0% |
$7,420
$36.92 p/Share
|
Mar 03
2025 |
NDAQ
|
Bryan Everard Smith
Executive Vice President |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 5.45% |
$289,730
$82.78 p/Share
|
Mar 03
2025 |
WEC
|
Gale E Klappa
Director |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 15.39% |
$5,386,500
$107.73 p/Share
|
Mar 03
2025 |
BKE
|
Dennis H Nelson
President & CEO |
SELL
Open market or private sale
|
Indirect | 15,340 Reduced 0.0% |
$606,083
$39.51 p/Share
|
Mar 03
2025 |
ORI
|
Craig R Smiddy
President & CEO |
SELL
Open market or private sale
|
Direct | 5,296 Reduced 3.69% |
$204,425
$38.6 p/Share
|
Mar 03
2025 |
WWD
|
Gregg C Sengstack |
SELL
Open market or private sale
|
Direct | 4,600 Reduced 20.86% |
$864,846
$188.01 p/Share
|
Mar 03
2025 |
ALTR
|
Amy Messano
Chief Marketing Officer |
SELL
Open market or private sale
|
Direct | 255 Reduced 1.08% |
$28,419
$111.45 p/Share
|
Mar 03
2025 |
ALTR
|
Raoul Maitra
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 240 Reduced 0.76% |
$26,748
$111.45 p/Share
|
Mar 03
2025 |
ALTR
|
Nelson Dias
Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 491 Reduced 0.85% |
$54,721
$111.45 p/Share
|
Mar 03
2025 |
ALTR
|
Brian Gayle
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 184 Reduced 1.0% |
$20,506
$111.45 p/Share
|
Mar 03
2025 |
ALTR
|
Jeffrey Marraccini
Officer |
SELL
Open market or private sale
|
Direct | 197 Reduced 3.43% |
$21,955
$111.45 p/Share
|
Mar 03
2025 |
ALTR
|
Stephanie Buckner
Chief Operating Officer |
SELL
Open market or private sale
|
Indirect | 62 Reduced 0.0% |
$6,909
$111.45 p/Share
|
Mar 03
2025 |
ALTR
|
Matthew Charles Brown
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 742 Reduced 1.07% |
$82,695
$111.45 p/Share
|
Mar 03
2025 |
ALTR
|
Gilma Saravia
Chief People Officer |
SELL
Open market or private sale
|
Direct | 264 Reduced 1.16% |
$29,422
$111.45 p/Share
|
Mar 03
2025 |
ALTR
|
Ravi Kunju
Chief Product Strategy Officer |
SELL
Open market or private sale
|
Direct | 121 Reduced 0.35% |
$13,485
$111.45 p/Share
|
Mar 03
2025 |
HURN
|
John Mccartney
Director |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.89% |
$75,565
$151.13 p/Share
|
Mar 03
2025 |
HURN
|
H Eugene Lockhart
Director |
SELL
Open market or private sale
|
Direct | 1,042 Reduced 8.56% |
$157,477
$151.13 p/Share
|
Mar 03
2025 |
CHD
|
Matthew Farrell
President and CEO |
SELL
Open market or private sale
|
Direct | 0 Reduced 0.0% |
$0
$111.21 p/Share
|
Mar 03
2025 |